Structural basis of CD4 downregulation by HIV-1 Nef
The HIV-1 Nef protein suppresses multiple immune surveillance mechanisms to promote viral pathogenesis and is an attractive target for the development of novel therapeutics. A key function of Nef is to remove the CD4 receptor from the cell surface by hijacking clathrin- and adaptor protein complex 2...
Saved in:
Published in | Nature structural & molecular biology Vol. 27; no. 9; pp. 822 - 828 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.09.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The HIV-1 Nef protein suppresses multiple immune surveillance mechanisms to promote viral pathogenesis and is an attractive target for the development of novel therapeutics. A key function of Nef is to remove the CD4 receptor from the cell surface by hijacking clathrin- and adaptor protein complex 2 (AP2)-dependent endocytosis. However, exactly how Nef does this has been elusive. Here, we describe the underlying mechanism as revealed by a 3.0-Å crystal structure of a fusion protein comprising Nef and the cytoplasmic domain of CD4 bound to the tetrameric AP2 complex. An intricate combination of conformational changes occurs in both Nef and AP2 to enable CD4 binding and downregulation. A pocket on Nef previously identified as crucial for recruiting class I MHC is also responsible for recruiting CD4, revealing a potential approach to inhibit two of Nef’s activities and sensitize the virus to immune clearance.
Crystallography and mutagenesis analyses examine how HIV-1 Nef interacts with AP2 to enable CD4 binding and downregulation and reveal the role of a Nef pocket that is also involved in downregulation of class I MHC. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author contributions: Y.K. performed protein expression, purification, binding assay, and crystallization. Y.K. and X.J. performed data collection, structure determination, model building, and refinement. M.S., C.S., and P.R. performed CD4 and MHC-I downregulation assays and mutagenesis. R.M.K. performed crosslinking-MS. I.E. performed integrative modeling. Y.K. and M.K.S. performed in vitro mutagenesis and fluorescence polarization assays. J.K. and R.S. contributed to protein expression and purification. Y.K., R.M.K., I.E., A.S., N.K., J.G., and X.J. designed the experiments. All contributed to data analysis. J.G. and X.J. supervised the project. Y.K., J.G., and X.J. wrote the manuscript. |
ISSN: | 1545-9993 1545-9985 1545-9985 |
DOI: | 10.1038/s41594-020-0463-z |